DETERMINING AND MODELING THE EFFICACY OF DRUG TREATMENT PLANS

1 . A method for identifying patient risk, the method comprising:

ingesting patient data relating to a plurality of patients received from at least one of a plurality of patient data providers;

importing the ingested data into at least one data matrix,

determining one or more relationships between the ingested patient data relating to a plurality of patients and previously ingested patient data, wherein at least one new enriched data set is created based on the determined one or more relationships;

importing the enriched data set into a machine learning module;

performing data mining on the enriched data set, using the machine learning module, to determine if a patient within the plurality of patients has a risk of developing a specified clinical indication.

2 . The method of claim 1 , wherein the machine learning module is configured to train an artificial intelligence system.

3 . The method of claim 1 , wherein the machine learning module is configured to train a rules-based recommendation system.

4 . The method of claim 3 , wherein the rules-based recommendation system includes rules for determining the appropriateness of a treatment.

5 . The method of claim 4 , wherein the treatment is a prescription medication.

6 . The method of claim 3 , wherein the configuration of the machine learning module to train a rules-based recommendation system includes using training data from a prescription medication data set.

7 . The method of claim 3 , wherein the configuration of the machine learning module to train a rules-based recommendation system includes using training data from a prescription medication data set.

8 . The method of claim 3 , wherein the risk of developing a specified clinical indication is presented with a confidence level associated with the risk determination.

9 . A method for simulating patient risk, the method comprising:

ingesting patient data relating to a plurality of patients received from at least one of a plurality of patient data providers;

importing the ingested data into at least one data matrix,

determining one or more relationships between the ingested patient data relating to a plurality of patients and previously ingested patient data, wherein at least one new enriched data set is created based on the determined one or more relationships;

importing the enriched data set into a machine learning module;

receiving simulation instructions, wherein the simulation instructions are indicative of one or more drug treatment plans;

using the machine learning module to simulate the one or more drug treatment plans; and

evaluating the efficacy of the one or more simulated drug treatment plans.

10 . The method of claim 9 , further comprising:

receiving simulation instructions from a healthcare provider, the simulation instructions being indicative of one or more treatment plans;

simulating the one or more treatment plans, application of best clinical practices for a desired clinical outcome, and identification of any gaps in care on said patient via the digital twin of said patient; and

evaluating efficacy of the one or more treatment plans.

11 . The method of claim 10 , further comprising:

simulating application of best clinical practices for a desired clinical outcome on said patient via the digital twin of said patient.

12 . The method of claim 10 , further comprising:

identifying any gaps in care provided to said patient using the digital twin of said patient.

13 . The method of claim 12 , wherein the one or more gaps in care include failure by one or more healthcare professionals to follow one or more established clinical standards of care in treating said patient.

14 . The method of claim 9 , further comprising:

determining one or more prognostication methods suitable for said population of patients using the machine learning module;

simulating the one or more prognostication methods on said population of patient via the digital twin of said population of patients; and

evaluating efficacy of the one or more prognostication methods.

15 . The method of claim 9 , further comprising:

receiving simulation instructions from a healthcare researcher, the simulation instructions including one or more research experiments;

simulating the one or more research experiments, and results of best clinical practices on at least one of said patient and said population of patients using at least one of the digital twin of said patient and the digital twin of said population of patients.

16 . The method of claim 9 , further comprising:

receiving simulation instructions from a healthcare researcher, the simulation instructions including one or more drug treatment regimens;

simulating the one or more drug treatment regimens on one or both of said patient and said population of patients vs. using at least one of the digital twin of said patient and the digital twin of said population of patients.

17 . The method of claim 9 , further comprising:

receiving sensor data from one or more Internet of Things (IoT) sensors related to one or both of said patient and said population of patients; and

updating at least one of the digital twin of said patient and the digital twin of said population of patients based on said population of patients based on the sensor data.

18 . The method of claim 9 , further comprising:

outputting the digital twin of said patient and the digital twin of said population of patients to a machine learning module of the healthcare data system;

simulating a future health state of said first population of patients based on the digital twin of said patient via the digital twin of said patient and the machine learning module;

simulating a future health state of said second population of patients based on the digital twin of said population of patients via the digital twin of said population of patients and the machine learning module;

updating the digital twin of said patient based on the simulation of the future health state of said patient;

updating the digital twin of said population of patients based on the simulation of the future health state of said population of patients; and

presenting to a healthcare worker healthcare research information determined to be relevant to at least one of said individual patient, said first population of patients, and said second population of patients.

19 . The method of claim 18 , wherein simulation of the future health state of said first population of patients and/or the future health state of said second population of patients is performed according to simulation instructions received from one or more of said healthcare workers.

20 . The method of claim 18 , wherein simulation of the future health state of said first population of patients and/or the future health state of said second population of patients is performed according to simulation instructions formed by the machine learning module.